Get notified of page updates

Search Results: Treatment + Pancreatic Cancer (1 results)

New Search
PRINTER FRIENDLY PAGE 1 through 1 of 1

Treatment
Phase 2 treatment study for advanced pancreatic and lung cancer

Testing a Combination of Immunotherapy and a Vaccine in People With Advanced Pancreatic or Lung Cancer

This is a Phase 2 treatment trial enrolling adults with advanced pancreatic cancer or advanced non-small cell lung cancer that has continued to grow despite standard immunotherapy.

Clinicaltrials.gov identifier: NCT06015724
Additional Results on Clinicaltrials.gov Treatment + Pancreatic Cancer + vaccine
4 results
Clinical Trial Official Title
NCT06202066 Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
NCT04157127 Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
NCT06782932 Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
NCT05013216 Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer

Sponsored By